Literature DB >> 35342472

Actualities in Involvement of Estrogens in the Pathogenesis of Colorectal Cancer.

R M Anghel1,2, G L Serbanescu1,2.   

Abstract

Gastrointestinal effects of estrogens are emerging as an important topic in colorectal cancer management. Current research demonstrated the link between inflammation and this malignancy, so important estrogen dependent mediators of the inflammatory response have been identified. Radioresistance and chemoresistance still represent an important cause of therapeutic failure in colorectal cancer and lead to further studies of colorectal carcinogenesis and predictive markers. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Colorectal cancer; Estrogens; Pathogenesis

Year:  2021        PMID： 35342472      PMCID： PMC8919495          DOI： 10.4183/aeb.2021.422

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN： 1841-0987            Impact factor:   0.877


  25 in total

1.  Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.

Authors:  Carolyn J Crandall; Kathleen M Hovey; Christopher A Andrews; Rowan T Chlebowski; Marcia L Stefanick; Dorothy S Lane; Jan Shifren; Chu Chen; Andrew M Kaunitz; Jane A Cauley; JoAnn E Manson
Journal:  Menopause       Date:  2018-01       Impact factor: 2.953

2.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

3.  Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age.

Authors:  Ross L Prentice; Aaron K Aragaki; Rowan T Chlebowski; Jacques E Rossouw; Garnet L Anderson; Marcia L Stefanick; Jean Wactawski-Wende; Lewis H Kuller; Robert Wallace; Karen C Johnson; Aladdin H Shadyab; Margery Gass; JoAnn E Manson
Journal:  Am J Epidemiol       Date:  2021-02-01       Impact factor: 4.897

4.  Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.

Authors:  Johanna Simin; Qing Liu; Xinchen Wang; Katja Fall; Cecilia Williams; Steven Callens; Lars Engstrand; Nele Brusselaers
Journal:  Acta Oncol       Date:  2021-04-16       Impact factor: 4.089

5.  Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.

Authors:  Edoardo Botteri; Nathalie C Støer; Solveig Sakshaug; Sidsel Graff-Iversen; Siri Vangen; Solveig Hofvind; Thomas de Lange; Vincenzo Bagnardi; Giske Ursin; Elisabete Weiderpass
Journal:  BMJ Open       Date:  2017-11-15       Impact factor: 2.692

Review 6.  G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis.

Authors:  Damian Jacenik; Ellen J Beswick; Wanda M Krajewska; Eric R Prossnitz
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

Review 7.  Sex Differences in the Incidence of Obesity-Related Gastrointestinal Cancer.

Authors:  Ji-Won Heo; Sung-Eun Kim; Mi-Kyung Sung
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

8.  17β-Estradiol reduces inflammation and modulates antioxidant enzymes in colonic epithelial cells.

Authors:  Hee Jin Son; Nayoung Kim; Chin-Hee Song; Sun Min Lee; Ha-Na Lee; Young-Joon Surh
Journal:  Korean J Intern Med       Date:  2018-10-22       Impact factor: 2.884

9.  Colorectal cancer incidence and mortality: the current status, temporal trends and their attributable risk factors in 60 countries in 2000-2019.

Authors:  Bin Lu; Na Li; Chen-Yu Luo; Jie Cai; Ming Lu; Yu-Han Zhang; Hong-Da Chen; Min Dai
Journal:  Chin Med J (Engl)       Date:  2021-07-07       Impact factor: 2.628
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.